Healthcare
Pharmaceuticals
Regulatory Compliance and Enforcement
Testimonial
We have advised pharmacies on the regulatory aspects of pharmaceutical compounding.
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch oncology company, developing small molecule inhibitors for the precision treatment of cancer, with the structuring and completion of its Series A financing round. We advised on the drafting of all corporate resolutions, conditions precedent and related filtering and closing matters.
Healthcare
Medical Devices
Financing and M&A
Testimonial
Axon assisted the shareholders of a Dutch medtech company, specialising in epilepsy detection devices, in the sale of the company to a Scandinavian healthcare technology group. We advised on the transaction structure, share purchase documentation and related matters.
Diagnostics
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch IVD company in securing a EUR 24M equity financing round, advising on the transaction structure, investment documentation and related matters.
Biotech
Diagnostics
Corporate, Governance and Boardroom Counselling
Due Diligence
Financing and M&A
Testimonial
Axon acted on behalf of an investor in connection with their investment in a clinical-stage biotech company developing first-in-class therapeutics and diagnostics for fibrosis. We conducted legal due diligence on the target company and reviewed the transaction documentation on behalf of the investors.
Biotech
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch cultivated materials company in securing a EUR 22M Series A financing round. We advised on the transaction structure, investment documentation and related matters.
Biotech
Pharmaceuticals
Commercial Contracts
Intellectual Property and Licensing
Testimonial
Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.
Agriculture
Biotech
Intellectual Property and Licensing
Testimonial
Axon advised a Dutch joint venture, that is active within the agri-food and agricultural biotechnology sector, on the transfer of its assets to a German investment fund. The transferred assets involved patent rights, plant breeders’ rights, trade secrets and biological materials.
Biotech
Corporate, Governance and Boardroom Counselling
Intellectual Property and Licensing
Spin-out and Starter Advisory
Testimonial
Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.
